Cyclosporin is a potent immunosuppressive drug effective in combating tissue rejection following organ transplantation. However, therapeutic doses in humans can cause a number of adverse side effects including renal and hepatic dysfunction, hypertension, neurotoxicity, lymphoma, abnormal glucose homeostasis, hypertrichosis and gingival hypertrophy.
The efficacy and degree of toxicity of cyclosporin is highly variable between individuals. However, intra- and inter- individual variablility in cyclosporin absorption, distribution and clearance is so great that standard dosing protocols based on median population values are considered inappropriate and monitoring of cyclosporin levels is required.
Dosages must be individualised to maintain Ciclosporin levels within the narrow therapeutic window that exists between inadequate immunosuppression from low doses, and toxic effects resulting from over administration.
Trough samples should be taken in all instances except for C2 cyclosporine, where samples are taken 2 hours post dose.
Reference or therapeutic ranges are not reported as therapeutic target ranges are applied on an individual basis dependent upon specialty, dosing, period in treatment regime and clinical status. Further advice can be obtained from the appropriate speciality.
Copyright UHB Pathology 2018
Protection of Personal Information – Clinical Laboratory Services comply with the Trust Data Protection Policy and have procedures in place to allow the Directorate and it’s employees to comply with the Data Protection Act 1998 and associated best practice and guidance.
University Hospitals Birmingham medical laboratories at Queen Elizabeth Hospital, Heartlands Hospital, Good Hope Hospital and Solihull Hospital are UKAS (United Kingdom Accreditation Service) accredited to the ISO 15189:2012 standard. For a list of accredited tests and other information please visit the UKAS website using the following link: https://www.ukas.com/find-an-organisation/
Tests not appearing on the UKAS Schedule of Accreditation currently remain outside of our scope of accreditation. However, these tests have been validated to the same high standard as accredited tests and are performed by the same trained and competent staff.
For further test information, please visit the test database: http://qehbpathology.uk/test-database
For further information contact Louise Fallon, Quality Manager, 0121 371 5962